Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

1
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
1
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.5K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K
Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

635
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
635
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep-Learning Algorithm Diagnostic Support for Usual Interstitial Pneumonia Pattern Recognition in Fibrotic Interstitial Lung Disease.

Respirology (Carlton, Vic.)·2026
Same author

Likelihood of Usual Interstitial Pneumonia: A Novel Approach to Prognosis for Pulmonary Fibrosis.

Respirology (Carlton, Vic.)·2026
Same author

The role of epigenetic regulation in idiopathic pulmonary fibrosis.

American journal of physiology. Lung cellular and molecular physiology·2025
Same author

A Comprehensive Review of Interstitial Lung Abnormalities.

Respirology (Carlton, Vic.)·2025
Same author

Pre-Treatment MMP7 Predicts Progressive Idiopathic Pulmonary Fibrosis in Antifibrotic Treated Patients.

Respirology (Carlton, Vic.)·2025
Same author

The Analysis of Proteomics by Machine Learning in Separating Idiopathic Pulmonary Fibrosis from Connective Tissue Disease-Interstitial Lung Disease.

American journal of respiratory and critical care medicine·2024

Related Experiment Video

Updated: Jun 9, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

19.8K

Contemporary Concise Review 2023: Interstitial lung disease.

Yuben Moodley1,2,3,4

  • 1School of Medicine, University of Western Australia, Crawley, Western Australia, Australia.

Respirology (Carlton, Vic.)
|October 22, 2024
PubMed
Summary

2023 saw key advances in Interstitial Lung Disease (ILD), linking pollution and genetics to Idiopathic Pulmonary Fibrosis (IPF) risk. New insights into IPF genetics, comorbidities like malnutrition, and innovative treatments emerged.

Keywords:
idiopathic pulmonary fibrosisinterstitial lung diseaselung diseases

More Related Videos

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

390
Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy
04:10

Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy

Published on: July 19, 2024

514

Related Experiment Videos

Last Updated: Jun 9, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

19.8K
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

390
Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy
04:10

Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy

Published on: July 19, 2024

514

Area of Science:

  • Pulmonology
  • Genetics
  • Environmental Health

Background:

  • Interstitial Lung Disease (ILD) encompasses a range of progressive lung disorders.
  • Idiopathic Pulmonary Fibrosis (IPF) is a major subtype with complex etiology.
  • Understanding recent advancements is crucial for clinical practice.

Purpose of the Study:

  • To review significant developments in Interstitial Lung Disease (ILD) in 2023.
  • To highlight new findings in the pathogenesis and genetics of Idiopathic Pulmonary Fibrosis (IPF).
  • To discuss novel diagnostic and therapeutic approaches for ILD.

Main Methods:

  • Literature review of 2023 publications on Interstitial Lung Disease.
  • Synthesis of findings related to genetic predispositions, environmental factors, and comorbidities.
  • Analysis of emerging treatment strategies and monitoring tools.

Main Results:

  • Increased recognition of pollution and genetic interactions in IPF risk.
  • Identification of novel genes linked to short telomere length and alveolar epithelial dysfunction in IPF.
  • Emergence of malnutrition as a significant comorbidity in ILD.
  • Bone morphogenic protein signaling implicated in lung remodeling in IPF.
  • 4-minute gait speed proposed as a novel disease monitoring tool.
  • New treatments like inhaled pirfenidone and efzofitimod (for sarcoidosis) discussed.

Conclusions:

  • Genetics play a critical role in IPF development and progression.
  • Environmental factors, particularly pollution, interact with genetic susceptibility.
  • Integrated management considering comorbidities like malnutrition is essential.
  • Novel therapeutic strategies and monitoring methods offer new hope for ILD patients.